Alyeska Investment Group
ELV icon

Alyeska Investment Group’s Elevance Health ELV Stock Holding History

Alyeska Investment Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.2M Buy
173,839
+98,839
+132% +$36.7M 0.17% 164
2026
Q1 		$22M Sell
75,000
-337,215
-82% -$111M 0.06% 314
2025
Q4 		$145M Buy
+412,215
New +$139M 0.41% 51
2020
Q3 		– Sell
-39,879
Closed -$10.5M – 503
2020
Q2 		$10.5M Sell
39,879
-786
-2% -$210K 0.16% 194
2020
Q1 		$9.23M Buy
+40,665
New +$11.1M 0.18% 135
2019
Q3 		– Sell
-251,870
Closed -$71.1M – 435
2019
Q2 		$71.1M Buy
251,870
+103,007
+69% +$28.1M 0.92% 27
2019
Q1 		$42.7M Sell
148,863
-91,974
-38% -$26.6M 0.56% 56
2018
Q4 		$63.3M Buy
240,837
+97,122
+68% +$26.7M 0.92% 22
2018
Q3 		$39.4M Sell
143,715
-183,351
-56% -$47.6M 0.43% 78
2018
Q2 		$77.9M Sell
327,066
-44,667
-12% -$10.3M 0.7% 37
2018
Q1 		$81.7M Sell
371,733
-55,378
-13% -$13M 0.68% 46
2017
Q4 		$96.1M Sell
427,111
-112,313
-21% -$23.9M 0.76% 39
2017
Q3 		$102M Sell
539,424
-13,077
-2% -$2.49M 0.76% 32
2017
Q2 		$104M Buy
552,501
+200,000
+57% +$35.9M 0.87% 25
2017
Q1 		$58.3M Buy
352,501
+329,735
+1,448% +$52.5M 0.47% 66
2016
Q4 		$3.27M Buy
+22,766
New +$3.05M 0.03% 360
2016
Q2 		– Sell
-169,123
Closed -$23.5M – 442
2016
Q1 		$23.5M Buy
+169,123
New +$22.6M 0.22% 166
2015
Q2 		– Sell
-162,047
Closed -$25M – 511
2015
Q1 		$25M Sell
162,047
-134,801
-45% -$19.2M 0.35% 114
2014
Q4 		$37.3M Buy
296,848
+167,074
+129% +$20.6M 0.64% 36
2014
Q3 		$15.5M Buy
+129,774
New +$14.9M 0.32% 116
2014
Q2 		– Sell
-219,353
Closed -$21.8M – 418
2014
Q1 		$21.8M Buy
219,353
+54,353
+33% +$4.92M 0.6% 42
2013
Q4 		$15.2M Buy
165,000
+20,000
+14% +$1.78M 0.6% 46
2013
Q3 		$12.1M Buy
145,000
+85,000
+142% +$7.28M 0.5% 74
2013
Q2 		$4.91M Buy
+60,000
New +$4.49M 0.24% 130

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alyeska Investment Group's ELV Position: Q2 2026 in Review

Alyeska Investment Group increased its Elevance Health (ELV) stake by 132% in Q2 2026, buying an estimated $36.7M and bringing the position to 173,839 shares worth $67.2M. The position accounts for 0.17% of the portfolio, ranked #164.

Alyeska Investment Group first reported a position in ELV in Q2 2013 and has held it in 24 quarters since. The position peaked at $145M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Alyeska Investment Group held 173,839 shares of Elevance Health worth $67.2M as of Q2 2026.
  • Alyeska Investment Group bought 98,839 Elevance Health shares in Q2 2026, an estimated $36.7M.
  • Elevance Health made up 0.17% of Alyeska Investment Group's portfolio in Q2 2026, its #164 holding.
  • Alyeska Investment Group first reported a position in Elevance Health in Q2 2013 and has held it in 24 quarters since.
  • Alyeska Investment Group's Elevance Health position peaked at $145M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.